**Pictures are of one product, in a single vial. Slight variations in color such as that of the cap are to be expected in the final product.
TAMOXIFEN 30 ML (20 MG/ ML)
Tamoxifen is a nonsteroidal selective estrogen receptor modulator (SERM). It competitively inhibits the binding of estradiol to estrogen receptors, thereby preventing the receptor from binding to the estrogen-response element on DNA. This results in a reduction in DNA synthesis and cellular response to estrogen. In addition to its activity as a SERM, tamoxifen is a potent and selective protein kinase C inhibitor, and is active in this regard at therapeutic concentrations. Tamoxifen is a long-acting SERM, with a nuclear retention of the ER–tamoxifen (or metabolite) complex of greater than 48 hours.
Liquid tamoxifen exhibits both estrogenic agonist and antagonist effects in different parts of the body of animal test subjects. In the breast tissue, it is an antagonist, causing antiestrogenic and antitumor effects. Through downstream intracellular processes, it slows cell cycling, which classifies it as cytostatic. In the bone, it stimulates estrogen receptors instead of blocking them, exerting an estrogenic agonist effect, and may prevent osteoporosis.
*The information presented here is intended for educational / informational purposes only
|Dimensions||1.2 × 1.2 × 3.9 in|